Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$0.96
$0.010.82%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.53% | 11.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.53% | 11.14% | |||
| Cost of Revenue | -1.51% | 9.06% | |||
| Gross Profit | 0.03% | 12.37% | |||
| SG&A Expenses | 2.85% | 13.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -140.85% | -2,331.81% | |||
| Total Operating Expenses | -0.21% | 10.80% | |||
| Operating Income | -1.65% | 12.35% | |||
| Income Before Tax | 14.27% | -16.84% | |||
| Income Tax Expenses | -9.99% | 4.42% | |||
| Earnings from Continuing Operations | 28.07% | -25.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.07% | -25.47% | |||
| EBIT | -1.65% | 12.35% | |||
| EBITDA | -0.83% | 11.16% | |||
| EPS Basic | 27.57% | -26.00% | |||
| Normalized Basic EPS | 14.36% | -17.35% | |||
| EPS Diluted | 27.57% | -26.00% | |||
| Normalized Diluted EPS | 14.36% | -17.35% | |||
| Average Basic Shares Outstanding | 0.05% | 0.83% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.83% | |||
| Dividend Per Share | 3.88% | 5.10% | |||
| Payout Ratio | -- | -1.00% | |||